A leading fund manager expects more near-term outperformance from this ASX 200 dividend stock. The post 3 reasons to buy this ...

Several DSOs specializing in oral and maxillofacial surgery have landed additional funding in recent years as investors continue to see the field for its growth potential. Hackensack, N.J.-based Max ...